GGrantIndex
← Search

TOPIC 319 PHASE I; RECOMBINANT RABBIT MONOCLONAL ANTIBODIES AS AFFINITY CAPTURES

$199,987N43FY2013CANIH

Avantgen, Inc., San Diego CA

Investigators

Abstract

Recombinant rabbit monoclonal antibodies as affinity captures for peptides

View original record on NIH RePORTER →
TOPIC 319 PHASE I; RECOMBINANT RABBIT MONOCLONAL ANTIBODIES AS AFFINITY CAPTURES · GrantIndex